Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979;8(Suppl 1):47S–54S. doi: 10.1111/j.1365-2125.1979.tb00456.x

Effects of temazepam, flurazepam and quinalbarbitone on sleep

Psychomotor and cognitive function

T Roth, P Piccione, P Salis, M Kramer, M Kaffeman
PMCID: PMC1429623  PMID: 41542

Abstract

1 The effect of temazepam 15 and 30 mg, flurazepam 15 and 30 mg, quinalbarbitone 100 and 200 mg and placebo were studied in 14 healthy male volunteers according to a Latin-square design. At 14-d intervals subjects received capsules 30 min before bedtime on 2 consecutive nights and were evaluated for objective sleep characteristics, for morning estimates of sleep characteristics, and for cognitive and psychomotive performance and subjective state at 3.5, 10.0 and 22.5 h after ingestion.

2 Changes in sleep induction and sleep maintenance were observed with temazepam 30 mg and flurazepam 30 mg. REM sleep was suppressed by quinalbarbitone, and by flurazepam 30 mg.

3 Flurazepam 30 mg had the greater effect on cognitive performance, whereas quinalbarbitone 20 mg had the greater effect on psychomotive performance. Subjective assessments of alertness were most affected by flurazepam, and by quinalbarbitone 200 mg.

4 The results suggest that temazepam produces less residual effects and is shorter acting than quinalbarbitone and flurazepam.

Full text

PDF
47S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bond A. J., Lader M. H. Residual effects of hypnotics. Psychopharmacologia. 1972;25(2):117–132. doi: 10.1007/BF00423189. [DOI] [PubMed] [Google Scholar]
  2. Epstein L. C., Lasagna L. A comparison of the effects of orally administered barbiturate salts and barbiturate acids on human psychomotor performance. J Pharmacol Exp Ther. 1968 Dec;164(2):433–441. [PubMed] [Google Scholar]
  3. Fuccella L. M., Tosolini G., Moro E., Tamassia V. Study of physiological availability of temazepam in man. Int J Clin Pharmacol. 1972 Nov;6(4):303–309. [PubMed] [Google Scholar]
  4. Hoddes E., Zarcone V., Smythe H., Phillips R., Dement W. C. Quantification of sleepiness: a new approach. Psychophysiology. 1973 Jul;10(4):431–436. doi: 10.1111/j.1469-8986.1973.tb00801.x. [DOI] [PubMed] [Google Scholar]
  5. JONSSON C. O., ANDERSEN K. [Experimental psychological tests with a new tranquilizer, nuncital]. Sven Lakartidn. 1960 Apr 14;57:1213–1222. [PubMed] [Google Scholar]
  6. KORNETSKY C., VATES T. S., KESSLER E. K. A comparison of hypnotic and residual psychological effects of single doses of chlorpromazine and secobarbital in man. J Pharmacol Exp Ther. 1959 Sep;127:51–54. [PubMed] [Google Scholar]
  7. Pfaff D. Effects of temperature and time of day on time judgments. J Exp Psychol. 1968 Mar;76(3):419–422. doi: 10.1037/h0025481. [DOI] [PubMed] [Google Scholar]
  8. Veldkamp W., Straw R. N., Metzler C. M., Demissianos H. V. Efficacy and residual effect evaluation of a new hypnotic, triazolam. J Clin Pharmacol. 1974 Feb-Mar;14(2):102–111. doi: 10.1002/j.1552-4604.1974.tb02299.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES